Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-3-12
pubmed:abstractText
The purpose of the present study was to examine the expression of interleukin (IL)-8 and IL-8 receptors and to evaluate the effects of IL-8 on human pancreatic cancer. We examined the expression of IL-8 and its two receptors (CXCR1 and CXCR2) in 40 surgically resected human pancreatic cancer tissues and in three different human pancreatic cancer cell lines (PANC-1, MIAPaCa-2 and Capan-2). The immunohistochemical analysis using specific antibodies demonstrated that positive staining for IL-8, CXCR1 and CXCR2 in surgically resected human pancreatic cancer was 50, 55 and 65%, respectively. Moreover, 40% of these cases were positive for both IL-8 and IL-8 receptors. In contrast, immunoreactive signals for those proteins were extremely suppressed in normal pancreatic tissues. All of the pancreatic cancer cell lines expressed IL-8 and IL-8 receptors at the RNA and protein levels. Receptor binding experiments using 125I-labeled IL-8 showed that PANC-1 cells had specific binding sites for IL-8. The cell proliferation assay demonstrated that IL-8 did not affect the growth of the three cell lines. However, treatment with IL-8 enhanced the invasiveness into Matrigel and increased the activity of matrix metalloproteinase (MMP)-2 in supernatants of the PANC-1 cells. These results demonstrate that IL-8 and IL-8 receptors are over-expressed in pancreatic cancer, and suggest that IL-8 regulates MMP-2 activity and plays an important role in the invasiveness of human pancreatic cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1019-6439
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
765-71
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12632066-Binding Sites, pubmed-meshheading:12632066-Blotting, Western, pubmed-meshheading:12632066-Cell Division, pubmed-meshheading:12632066-Cell Line, Tumor, pubmed-meshheading:12632066-Dose-Response Relationship, Drug, pubmed-meshheading:12632066-Gelatin, pubmed-meshheading:12632066-Humans, pubmed-meshheading:12632066-Immunohistochemistry, pubmed-meshheading:12632066-Interleukin-8, pubmed-meshheading:12632066-Matrix Metalloproteinase 2, pubmed-meshheading:12632066-Neoplasm Invasiveness, pubmed-meshheading:12632066-Pancreatic Neoplasms, pubmed-meshheading:12632066-Precipitin Tests, pubmed-meshheading:12632066-Protein Binding, pubmed-meshheading:12632066-RNA, pubmed-meshheading:12632066-Receptors, Interleukin-8A, pubmed-meshheading:12632066-Receptors, Interleukin-8B, pubmed-meshheading:12632066-Recombinant Proteins, pubmed-meshheading:12632066-Reverse Transcriptase Polymerase Chain Reaction
pubmed:year
2003
pubmed:articleTitle
Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.
pubmed:affiliation
Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8551, Japan. ykuwada@hiroshima-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't